(S) -3- (4- (4- ((14-Azido-3,6,9,12-tetraoxatetradecyl) oxy) naphthalen-1-yl) phenyl) -3- (2- (4- ((4-methylpyridin-2-yl) amino) butanamido) acetamido) propanoic acid compound (trifluoroacetate)
Selected Variant
HY-W882830-01
Size: 1 mg
(S) -3- (4- (4- ((14-Azido-3,6,9,12-tetraoxatetradecyl) oxy) naphthalen-1-yl) phenyl) -3- (2- (4- ((4-methylpyridin-2-yl) amino) butanamido) acetamido) propanoic acid compound trifluoroacetate is a drug intermediate for synthesis of various active compounds.
Product Specifications
CAS Number
2320477-41-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Others
Purity
99.78
Smiles
OC(C(F)(F)F)=O.[N-]=[N+]=NCCOCCOCCOCCOCCOC1=CC=C(C2=CC=C(C=C2)[C@H](CC(O)=O)NC(CNC(CCCNC3=CC(C)=CC=N3)=O)=O)C4=C1C=CC=C4
Molecular Formula
C43H52F3N7O11
Molecular Weight
899.91
Precautions
H302, H315, H319, H335
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog